In Vitro Technologies, Inc. (IVT) and SOLVO Biotechnologies Inc. Announce North American (US and Canada) Distribution Agreement
Continuing with IVT's commitment to bring an extensive line of solutions for drug discovery and development research, IVT and SOLVO have collaborated to leverage IVT's strength in the marketplace and SOLVO's innovative Membrane Transporter products.
"By now, it is common knowledge among researchers that ABC transporters play a key role in the function of the blood-brain barrier (BBB), blood-CSF barrier, blood-testis barrier, intestinal epithelia (absorption), airway epithelia, liver epithelia and the kidney epithelia, " explained Gábor Heltovics, SOLVO's Business Development Director. "SOLVO's leading in vitro assay systems are designed to detect interaction of test compounds with a wide array of ABC Transporter proteins found at these vital pharmacological barriers. Our products are widely used for in vitro ADME/Tox, DMPK, oncology drug research and multi-drug resistant (MDR) modulating agent discovery. We welcome the opportunity to work with In Vitro Technologies, Inc. as an ideal partner to further expand the usage of our products".
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.